Saturday, December, 15, 2018 12:25:17

Cobra Biologics with GE Healthcare and CPI to develop AAV vectors

Cobra Biologics, an international biologics and pharmaceuticals contract development and manufacturing organization recently announced that it will be collaborating with UK-based technology innovation foundation, Centre for Process Innovation (CPI) and GE Healthcare Life Sciences. The aim of the three-way partnership is to increase the strength …

Tris Pharma acquires NextWave Pharmaceuticals, expands ADHD portfolio

Tris Pharma, technology-based therapeutic products developer recently acquired NextWave Pharmaceuticals, a subsidiary of Pfizer, the American pharmaceutical corporation. The sum involved in the acquisition has not been disclosed. According to reliable sources, the acquisition will enable Tris Pharma to expand its product offering in the …

Japan launches world’s first mini space elevator to reach ISS

Japan’s space agency Japan Aerospace Exploration Agency or JAXA recently launched its cargo spacecraft, Kounotori-7, to the International Space Station (ISS), that carried the world’s first mini space elevator. The experiment was conducted under the auspices of researchers of Shizuoka University in Japan. As per …

Ariel launches genomic tool for early diagnosis of pancreatic illness

Ariel Precision Medicine Inc., a Pennsylvania-based digital health care company, has reportedly announced the launch of a new cloud-based genomic tool ArielDx® that would simplify diagnosis and treatment of pancreatic diseases. Reports cite, ArielDx is already available for purchase on the company’s website through prescription …

Carrefour denies approaching rival Casino over a possible tie-up

One of the biggest supermarket groups in France Carrefour has reportedly denied having approached opponent Casino for a plausible partnership. As per trusted sources, Casino claimed that its board had collectively agreed to reject a tie-up approach from Carrefour. The difficulties being presently faced by …

Roche announces global availability of FoundationOne®Liquid

Roche AG, a Swiss multinational healthcare company has recently announced the availability of a next-gen liquid biopsy test, FoundationOne®Liquid. The Swiss company also claims that the liquid biopsy would offer patients suffering with solid tumors a quick and convenient testing option, just by diagnosing a single …